KUALA LUMPUR: CIMB Equities Research is maintaining its sum-of-parts based target price of RM10.20 and Neutral call for Sime Darby on news about its plan for a potential healthcare joint venture with an Australian partner.
The research house said on Thursday it was positive on news that Sime was in talks with Australia's Ramsay Health Care about the JV.
Already a subscriber? Log in.
Win a prize this Mother's Day by subscribing to our annual plan now! T&C applies.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!